CANDY WRAY: Open Payments
NPI 1619450095 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 76 payments from 21 companies in 2025. Trend: 2023 $1,334 · 2024 $959 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 12 | $410 |
| Otsuka America Pharmaceutical, Inc. | 12 | $212 |
| AstraZeneca Pharmaceuticals LP | 9 | $209 |
| PFIZER INC. | 7 | $142 |
| Teva Pharmaceuticals USA, Inc. | 1 | $92 |
| ABBVIE INC. | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 3 | $53 |
Products named: INVEGA SUSTENNA, REXULTI, BREZTRI, NURTEC ODT, UZEDY, CAPLYTA, TRINTELLIX, VRAYLAR.
Industry payments across AR — which companies pay providers there.
